共 28 条
- [21] Atorvastatin vs. Rosuvastatin for Contrast-Induced Nephropathy Prevention in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials and Propensity-Score Matching JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 353 - 353
- [22] Roxadustat vs. Erythropoiesis-Stimulating Agents and the Effect on Lipid Profile in Dialysis-Dependent Patients With Anemia of Renal Disease: A Meta-Analysis of Phase 3 Randomized Controlled Trials JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 245 - 245
- [25] 5-YEAR OUTCOME OF PERCUTANEOUS CORONARY INTERVENTION VS. CORONARY ARTERY BYPASS SURGERY FOR PATIENTS PRESENTING WITH UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND PROPENSITY SCORE ADJUSTED STUDIES JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1536 - 1536
- [27] COMPARISON OF SHORT-TERM, MID-TERM AND LONG-TERM MORTALITY IN PATIENTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE TREATED WITH DRUG-ELUTING STENTS VS. BYPASS SURGERY: INSIGHTS FROM AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1534 - 1534
- [28] Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F50 - F60